Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 27, 2016
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - June 27, 2016

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/26/16 - Data in The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8-Month Increase in Overall Survival in Patients with Advanced Soft Tissue Sarcoma, as...
Data in The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8- Month Increase in Overall Survival in Patients with Advanced Soft Tissue Sarcoma, as Reported by Lilly and Memorial Sloan Kettering Researchers. By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Eli Lilly and Company announced that The Lancet published detailed
6/26/16 - Investigators at Chongqing University Have Reported New Data on Autacoids (Identification of the inhibitory mechanism of FDA approved selective...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Data detailed on Biological Factors have been presented. According to news reporting out of Chongqing, People's Republic of China, by NewsRx editors, research stated, "Antidepressants selectively inhibiting serotonin reuptake represent a highly effective drug class, and novel.
6/26/16 - Switzerland : Pharma sector gets new ISO tool for drug identification [TendersInfo (India)]
With hundreds of thousands of prescription drugs on the market, the pharmaceutical sector faces an increasingly complex and risky challenge. Rapid growth in the number of available medications may be contributing to increased uncertainties. Lisa Spellman, Director of Global Standards for the American Health Information Management Association and...
6/26/16 - Tagrisso Osimertinib Shows Clinical Activity in Patients with Leptomeningeal Disease from Lung Cancer
By a News Reporter-Staff News Editor at Heart Disease Weekly AstraZeneca announced clinical and safety data for osimertinib in patients with leptomeningeal disease, a complication of epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer, 1 where cancer cells spread to the cerebrospinal fluid. The updated BLOOM Pha
6/26/16 - Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions
By a News Reporter-Staff News Editor at Heart Disease Weekly Takeda Pharmaceuticals Company Limited, will present eight abstracts at the American Diabetes Association's 76 Scientific Sessions, which takes place in New Orleans, LA, on June 10-14, 2016. "Type 2 diabetes is a progressive disease that can lead to serious cardiovascular comorbidities
6/26/16 - United Kingdom : Hikma acquires six injectable products in Europe [TendersInfo (India)]
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, announces that it has agreed to acquire a portfolio of six injectable products and their related customer contracts from Pfizer Inc.. The divestiture of these products was mandated by the European Commission as a condition to Pfizers acquisition of Hospira and the Europ
6/25/16 - "Methods for Treating Dry Eye Disease by Administering an Il-6r Antagonist" in Patent Application Approval Process (USPTO 20160152717)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAO, Jingtai; HU, Ying; ROMANO, Carmelo; WIEGAND, Stanley J., filed on December 1, 2015, was made available online on June 9, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent appli
6/25/16 - 'Imagine Me Gone', by Adam Haslett - review
In Adam Haslett's beautiful new novel, Imagine Me Gone, mental illness rips through one New England family over the course of four decades. Under the care of his father's psychiatrist, Michael falls into a vicious cycle of prescription-drug dependence while his younger and more capable siblings, Celia and Alec, spend much of their adult lives strug
6/25/16 - Alliance Pharma plc (APH) Given Buy Rating at Numis Securities Ltd [Jerusalem Post (Israel)]
Alliance Pharma plc stock had its buy rating reaffirmed by investment analysts at Numis Securities Ltd in a report released on Friday. Shares of Alliance Pharma plc opened at 44.6875 on Friday. Alliance Pharma plc has a 1- year low of GBX 39.50 and a 1- year high of GBX 63.00.
6/25/16 - Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes (EBV-CTLs)... [Daily News Egypt]
Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes from European Medicines Agency. -Atara Biotherapeutics, Inc., a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases, today announced...
6/25/16 - BlueTheory Announces Rebrand to BTC Network New Business Model to Streamline All Clinical Trial Needs [Khaleej Times (United Arab Emirates)]
BlueTheory Clinical Trials, a clinical research network company headquartered in Boston, Massachusetts has been partnering with pharmaceutical and contract research organizations to bring treatments and devices to the market since its inception. Today, BTC Network has grown to represent 63 full service, multi-specialty clinical research sites acros
6/25/16 - Immuron Signs Shigella Vaccine Development Agreement with US Army [Daily News Egypt]
-Australian microbiome biopharmaceutical company Immuron Limited, is pleased to announce that the Company has executed Research and Development Collaboration Agreement for the development of a Shigella vaccine with the Walter Reed Army Institute of Research. Established in 1893, and based in Silver Spring, Maryland, the Walter Reed Army Institute o
6/25/16 - INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Chiasma, Inc. and Reminds Investors with Losses to Contact the Firm
Khang& Khang LLP announces that a class action lawsuit has been filed against Chiasma, Inc.. The Company failed to disclose that the Phase 3 clinical trial for its oral octreotide, Mycapssa, which was conducted before the July 15, 2015 IPO, was insufficient to prove efficacy and secure FDA approval. On April 18, 2016 the Company announced that the
6/25/16 - Natsimbio may become sole supplier of blood-plasma and other drugs to Russian government [Khaleej Times (United Arab Emirates)]
The Russian government has appointed the National immuno-biological company, the recently established Russian drugmaker which is part of the Russian state and defense corporation Rostec, as sole supplier of blood plasma drugs for the period of 2016-2017 years through the signing of a contract with the company. This has already been criticized by ot
6/25/16 - New diagnostic agent in focus [Gulf Daily News (Bahrain)]
Bahrain: The use of 5- Aminolevulinic as a diagnostic and therapeutic agent in medicine was the focus of a symposium organised by the Royal College of Surgeons in Ireland Medical University of Bahrain in collaboration with Japanese pharmaceutical company SBI Pharma.
6/25/16 - OBS Pakistan acquiring Merck Serono [Daily News Egypt]
OBS Pakistan, which has a taste for multinational companies, is acquiring Pakistan operations of German based Merck Serono, The News has learnt. OBS Pakistan earlier acquired MSD Pakistan in 2010 and now the locally owned pharmaceutical giant is after Merck Serono. Arshad Saeed said the overly regulated pharmaceutical market of Pakistan was no more
6/25/16 - Pharma Bureau urges govt to 'learn' from regional players
Pharma Bureau, the representative body of the research based multinational pharmaceutical companies operating in Pakistan, has suggested the government to follow the Indian example of revising its drugs law. The Indians are trying to help their pharmaceutical industry and Pakistani authorities should learn from this positive step of Indian governme
6/25/16 - PHARMA BUREAU URGES GOVT TO LEARN FROM REGIONAL PLAYERS [Pakistan Observer]
Pharma Bureau, the representative body of the research based multinational pharmaceutical companies operating in Pakistan, has suggested the government follow the Indian example of revising its drugs law. But that has now been withdrawn as the Indian authorities have realized, as they look to bringing in huge amounts of foreign investment, that the
6/25/16 - Sabin Vaccine Institute partners with King Saud University to build vaccine research and development capacity in Saudi Arabia [Saudi Gazette, The]
The Sabin Vaccine Institute is partnering with King Saud University in Riyadh, Saudi Arabia, to advance vaccine research and development capacity in the Middle East and North Africa. In collaboration with the Prince Naif Bin Abdulaziz Health Research Center at King Saud University and Baylor College of Medicine, the goal of the project is to equip
6/25/16 - SC requests solicitor general to consider on biosimilars [National Iraqi News Agency (Iraq)]
Novartis has crossed all of the legal hurdles and launched its biosimilar of Neupogen, but its patent fight with Amgen was extended when the Swiss drugmaker asked the U.S. Supreme Court to get involved. In question are a number of issues that are key to Novartis ambitious biosimilars plans going forward; those issues will determine in whose pocket,
6/25/16 - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Chiasma, Inc. of Class Action Lawsuit and Upcoming... [National Iraqi News Agency (Iraq)]
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Chiasma, Inc. of Class Action Lawsuit and Upcoming Deadline CHMA. -Pomerantz LLP announces that a class action lawsuit has been filed against Chiasma, Inc. and certain of its officers. The class action, filed in United States District Court, District of Mas
6/25/16 - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and... [FARS News Agency]
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline EGRX. -Pomerantz LLP announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. and certain of its officers. The class action, filed in United States Di
6/25/16 - T3D Therapeutics Receives FDA Approval for a 6-Month, Open-Label Extension to its Phase 2a Trial of T3D-959 for Treatment of Mild to Moderate... [Seven Days (United Arab Emirates)]
-T3D Therapeutics, Inc., a clinical stage drug development company targeting Alzheimers disease, is announcing that the U.S. Food and Drug Administration has granted approval for a 26- week, open-label extension to its 2- week Phase 2 a clinical trial of T3D-959 in a limited number of subjects who completed the main Phase 2 a study for the treatmen
6/25/16 - Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020 [Khaleej Times (United Arab Emirates)]
The major vendors in the market are AbbVie, F. Hoffmann-La Roche, Gilead Sciences, Johnson& Johnson, Novartis, and Teva Pharmaceuticals. Companies such as BioLineRx, Emergent BioSolutions, Infinity Pharmaceuticals, and TG Therapeutics are expected to enter the market during the forecast period. Any company that manufactures and markets drugs that c
6/25/16 - World Companion Diagnostic Tests Market Report 2016 [Daily News Egypt]
-Research and Markets has announced the addition of the "The World Market for Companion Diagnostic Tests" report to their offering. The World Market for Companion Diagnostics The World Market for Companion Diagnostics covers the world market for companion diagnostic and personalized medicine diagnostics. The phrase Companion Diagnostics Market...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415